What we have learned about intrapartum fetal monitoring trials in the MFMU Network

Steven L. Bloom, Michael Belfort, George Saade

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

Original languageEnglish (US)
JournalSeminars in Perinatology
DOIs
StateAccepted/In press - 2016

Fingerprint

Fetal Monitoring
Technology
Oximetry
Cardiotocography
Auscultation
Fetal Heart
Pregnant Women
Electrocardiography

Keywords

  • Fetal pulse oximetry
  • Fetal ST segment analysis
  • Intrapartum fetal monitoring

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

What we have learned about intrapartum fetal monitoring trials in the MFMU Network. / Bloom, Steven L.; Belfort, Michael; Saade, George.

In: Seminars in Perinatology, 2016.

Research output: Contribution to journalArticle

@article{e565ca3057d3492ca202186b817c8353,
title = "What we have learned about intrapartum fetal monitoring trials in the MFMU Network",
abstract = "The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.",
keywords = "Fetal pulse oximetry, Fetal ST segment analysis, Intrapartum fetal monitoring",
author = "Bloom, {Steven L.} and Michael Belfort and George Saade",
year = "2016",
doi = "10.1053/j.semperi.2016.03.008",
language = "English (US)",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - What we have learned about intrapartum fetal monitoring trials in the MFMU Network

AU - Bloom, Steven L.

AU - Belfort, Michael

AU - Saade, George

PY - 2016

Y1 - 2016

N2 - The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

AB - The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

KW - Fetal pulse oximetry

KW - Fetal ST segment analysis

KW - Intrapartum fetal monitoring

UR - http://www.scopus.com/inward/record.url?scp=84964625760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964625760&partnerID=8YFLogxK

U2 - 10.1053/j.semperi.2016.03.008

DO - 10.1053/j.semperi.2016.03.008

M3 - Article

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

ER -